Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer | NeoGenomics Laboratories

Publication date

Thu, 03/17/2022 - 12:00

Category

Year

External link

https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2822%2900123-5

Division